InsiderClue
← All stocks

Apogee Therapeutics, Inc.

APGE Net selling
CIK 0001974640 #925 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$174.16M
$34.80M on a plan · $5.84M straight out of an exercise
Sold at will
$133.53M
1 of 83 sales
Net
−$174.16M
−$133.53M against sales at will

By person

8 insiders · 86 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fairmount Funds Management LLC entity
Director
—
$133.53M (1)
−$133.53M
340,855
0.4524%
$45.73M
−86.3%
HENDERSON MICHAEL THOMAS
Chief Executive Officer
—
$28.39M (33) scheduled
−$28.39M
0
0.0000%
$0.00
−100.0%
Dambkowski Carl
Chief Medical Officer
—
$10.15M (27) scheduled
−$10.15M
0
0.0000%
$0.00
−100.0%
Henderson Jane
Chief Financial Officer
—
$2.09M (22) scheduled
−$2.09M
0
0.0000%
$0.00
−100.0%
Shah Nimish P
Director
—
—
—
0
0.0000%
$0.00
−100.0%
McKenna Mark C.
Director
—
—
—
0
0.0000%
$0.00
—
JONES WILLIAM A JR
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Fox Jennifer A.
Director
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

3
Insider
Date
Role
Action
Shares
Price
Amount
Fairmount Funds Management LLC
7 Aug 2026
Director
Exercised, kept indirect
10,370
$43.85
$454.72K
Fairmount Funds Management LLC
7 Aug 2026
Director
Exercised, kept indirect
31,838
$17.00
$541.25K
HENDERSON MICHAEL THOMAS
16 Apr 2026
Chief Executive Officer
Exercised, kept
3,000
$22.86
$68.58K
Show all 86 transactions →

What was left out

Form 4 filings counted 58
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 57
Sales straight out of an exercise 25
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 3,727,244
History held since 17 Jul 2023